Oklo Inc. [NYSE: OKLO] fell 6% on May 13 after reporting first-quarter 2026 results that showed widening losses and rising cash burn, and continued lower on May 14 as investors also digested the company’s decision to file a new $1 billion equity offering, raising dilution concerns on top of the headline miss.

The headline numbers confirmed what investors feared: net losses widened sharply to $33.1 million in Q1 2026 from $9.8 million in the year-ago quarter, with an operating loss of $51.2 million as the company accelerated spending on reactor licensing, engineering, isotope research, and commercial development, while still generating zero revenue.

Operating cash outflow of $17.9 million in the quarter, up from $12 million a year ago, represents a meaningful acceleration in burn even though Oklo exited the quarter with approximately $2.5 billion in cash and marketable securities, giving the company a runway that extends well beyond any immediate need for additional capital.

That is what makes the new $1 billion at-the-market equity offering puzzling to some investors: with guidance pointing to full-year 2026 cash burn of only $80 million to $100 million, the additional equity issuance suggests management is beginning to pre-fund the construction of actual nuclear powerhouses, a capital expenditure category orders of magnitude larger than current operating expenses.

Building Aurora powerhouses, Oklo’s fast-fission commercial reactors designed to run on both fresh and recycled nuclear fuel, is exactly the kind of capital-intensive undertaking that requires a substantial funding buffer built years in advance of first construction milestones.

The company expects to deploy its first Aurora powerhouse no earlier than 2028, meaning revenue generation remains years away, but in the interim, Oklo must demonstrate consistent technical and regulatory progress to maintain investor confidence and justify its current $12 billion market capitalisation.

The most important near-term catalyst on the horizon is the company’s Groves Isotope Test Reactor in Texas, operated by its Atomic Alchemy subsidiary, which is targeting nuclear criticality by July 4, 2026, as part of the Department of Energy’s initiative to have advanced reactors achieve criticality by that national deadline.

Achieving criticality would prove that Oklo’s fast-fission design can sustain a controlled nuclear chain reaction, providing the first independent physical validation that the technology works outside of computer simulations and design documents, and transforming Oklo from a pure development-stage company into one that has demonstrated real-world reactor operation.

The stock could recover substantially if pre-criticality testing progress is announced or confirmed in the coming weeks, as that milestone would provide the kind of tangible technical evidence that could reignite institutional and retail interest despite the near-term dilution and loss headwinds.